Featured Articles

GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...

It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...

PharmaMar enters into a distribution license agreement with Megapharm for the commercialisation of anticancer drug Aplidin (plitidepsin) in Israel derived from marine. As per the…
Read More...

Clinical biopharmaceutical company, Liquidia dedicated to accelerate the performance of precision medicine by accurately engineering drug particles announces to commence the evolution…
Read More...

HyLeukin is an immuno-oncology agent comprised of an optimally engineered Interleukin-7 (IL-7) molecule based on Genexine's proprietary long-acting platform technology. Genexine…
Read More...

Mallinckrodt announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets. The transaction was…
Read More...

Teva Pharmaceutical Industries Ltd., announced the exclusive launch of a generic version of Reyataz®1 (atazanavir) capsules in the U.S. Atazanavir sulfate capsules are a protease…
Read More...

Recipharm AB (publ) announces that it has reached an agreement to acquire the remaining 26 per cent of the shares of Nitin Lifesciences Limited which were owned by members of the…
Read More...

Nanobiotix SA Announces that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) Application for NBTXR3, a first-in-class nanoparticle designed…
Read More...

Avista Pharma Solutions has completed extensive facility upgrades at its Longmont, Colorado site, expanding its drug product manufacturing footprint by approximately 20,000 square feet…
Read More...

Regeneron Pharmaceuticals and ISA Pharmaceuticals announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer,…
Read More...

Abzena plc has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate…
Read More...

An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly…
Read More...

GSK and Medicines for Malaria Venture (MMV) announced the submission of a new drug application (NDA) by GSK to the United States Food and Drug Administration (FDA), seeking approval of…
Read More...

Brammer Bio announced the completion of renovations and launch of its late-stage clinical capacity and commercial-ready cGMP manufacturing site in Cambridge, Massachusetts for gene…
Read More...

Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, will expand its manufacturing operations in…
Read More...

Arvinas LLC announced it has expanded its ongoing license agreement with Genentech, a member of the Roche Group, for the development of new therapeutics using Arvinas' novel PROTAC…
Read More...

Avista Pharma Solutions, Inc. has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site. During this expansion, the…
Read More...

Cambrex Corporation announced that it has completed an expansion of cGMP small scale capacity at its Charles City, Iowa plant. The project has seen the installation of two 500…
Read More...

Neurimmune announced that it has entered into a collaboration with Ono Pharmaceutical Co., Ltd. focused on the development of human antibodies against a novel therapeutic target for…
Read More...